Display search results for ** instead (39 products)

Showing 1-10 of 39

30 Nov 2020  |  Global

Analysing Sepsis Management Part II: Treatments

Recent developments in Sepsis Treatment focused towards antibiotics, inhibitors, antibodies, peptides, recombinant proteins, antibacterial, antifungal, antivirals, vaccines, and probiotics

Sepsis is a life-threatening condition caused by overactivation of host immune system upon infections which may lead to organ failure and potentially death. World Health Organization designates sepsis as a global public health priority. Several studies conducted to understand the molecular basis of sepsis, septic shock, and organ failure. Despite e...

USD 4,950.00

USD 4,455.00 save 10 %

04 Dec 2020  |  Global

Frost Radar™: Digital Biomarkers Through Connected Devices, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

High prevalence of complex diseases, high investments and low success rate associated with drug development, are making the health industry appeal for innovative technologies that can enhance understanding of complex diseases, contribute to the development of personalized treatments, accelerate clinical trial activities, and lower the R&D expenditu...

USD 4,950.00

USD 4,455.00 save 10 %

09 Dec 2020  |  Global

Frost Radar™: Microbiome Therapeutics, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Microbiome present in the human body has a major role to play in the overall functioning of the human body. Human microbiota consists of a diverse population of bacterial, viral and eukaryotic communities and is present on skin, nasopharynx, oral cavity, respiratory tract, gastrointestinal tract and female reproductive tract. The naturally occurri...

USD 4,950.00

USD 4,455.00 save 10 %

23 Jun 2021  |  Global

Global RNA Therapeutics:Technology Growth Opportunities

Advances in RNA Modifications, Formulation, and Stabilization to Drive Growth of RNA Therapeutics

RNA therapeutics is a rapidly expanding area of next-generation biological drugs. RNA is a versatile molecule and naturally regulates gene expression, either by upregulation or downregulation. This function is employed to design novel RNA therapeutics. The fundamentals of RNA therapeutics consists of delivering functional RNA at a target; however, ...

USD 4,950.00
15 Apr 2021  |  Global

Advanced Micro- and Nanofluidics Revolutionizing the Point of Care Diagnostic Industry

Disruptive microfluidic technologies enabling decentralization of diagnostic tests

Microfluidics which manipulate small volumes of fluid in microchannels enable gentle manipulation of cells and molecules and precise control of experimental conditions. It allows miniaturization of bulk assays in small devices requiring small volumes of samples and reagents and integration of several components for multiplexing analysis and achievi...

USD 4,950.00
27 Jul 2021  |  Global

Wearable Artificial Organ Growth Opportunities

Technological Innovations Enabling Remote Monitoring and Home Care for Organ Dysfunction

Healthcare providers typically manage kidney failure, diabetes, and respiratory failure with large, bulky medical equipment in a hospital setting. Conventional interventions typically reduce patient mobility; the treatment burden, mental anxiety, potential for non-compliance, and other drawbacks for specific therapies can result in poor health outc...

USD 4,950.00
19 Jul 2021  |  Global

Respiratory Health Management Technology Growth Opportunities

Smart and Portable Solutions Are In Demand

Respiratory diseases are related to the airways and the structures of the lungs. They can affect air sacs, interstitium, blood vessels, pleura, and chest wall. Common respiratory diseases include chronic obstructive pulmonary disease (COPD), asthma, pulmonary hypertension, and occupational lung disease. According to the World Health Organization, m...

USD 4,950.00
15 Dec 2020  |  Global

Frost Radar™: Advanced Antibodies, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

With advances in antibody-based therapies, bispecific antibodies (bsAbs) have gained momentum in the last few years after the regulatory approvals of Amgens blinatumomab (Blincyto®) and Chugais Hemlibra for Hemophilia A. The key advantage of bsAbs lies in their ability to bind two different epitopes or antigens, thereby overcoming the limitations ...

USD 4,950.00

USD 4,455.00 save 10 %

29 Oct 2020  |  Global

Frost Radar™:Transformative Influenza Vaccines, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Influenza causes respiratory diseases and often leads to large epidemics. Every year about 290,000 to 650,000 people die due to influenza worldwide. Anti-viral drugs available to treat influenza have many limitations making vaccination the most effective tool to prevent seasonal and pandemic influenza outbreaks. Influenza vaccination is highly reco...

USD 4,950.00

USD 4,455.00 save 10 %

24 Dec 2020  |  Global

Emerging Neuromodulation Technologies Enabling Growth Opportunities in Mental Health Care

Breakthrough Innovations in Transcranial Electrical Stimulation, Transcranial Magnetic Stimulation, Cranial Electrotherapy Stimulation and other Non-invasive Neuromodulation Therapies Bolstering the Psychiatric Toolbox

The treatment of mental health disorders using pharmaceuticals and psychotherapy are plagued with limitations such as therapy-related adverse effects, and inability to provide effective remission. This has driven the use of neuromodulation techniques for managing these conditions. However, these traditional neuromodulation therapies have their shar...

USD 4,950.00

USD 4,455.00 save 10 %

Showing 1-10 of 39